Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phasesYe Guo, Jin Li, Yueyin Pan et al.|European Journal of Cancer|2022Cited by 57
Claudin18.2 (CLDN18.2) expression and efficacy in pancreatic ductal adenocarcinoma (PDAC): Results from a phase I dose expansion cohort evaluating IBI343.Xianjun Yu, Hui Zhou, Jieer Ying et al.|Journal of Clinical Oncology|2025Cited by 10
SIK2 activates the autophagy‒apoptosis pathway through SP1 regulation to inhibit the progression of hepatocellular carcinomaSheng Fan, Yueyin Pan|Frontiers in Pharmacology|2025Cited by 0